期刊名称：JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
As the official publication of the American Academy of Dermatology, the Journal is dedicated to the clinical and continuing education needs of the entire dermatologic community and is internationally known as the leading journal in the field. Original, peer-reviewed articles cover clinical and investigative studies, treatments, new diagnostic techniques, and other topics relating to the prevention, diagnosis, and treatment of disorders of the skin. Included are CME articles based on the Core Curriculum of the American Academy of Dermatology. The Journal is also recommended for purchase in the Brandon-Hill study, Selected List of Books and Journals for the Small Medical Library.
Instructions to Authors
Information for authors
The Information for Authors undergoes continuous revision. The most current version can be found at www.eblue.org. All manuscript submissions must include the copyright transfer form, the conflict of interest disclosure form, the authorship statement (attestation) form, and the manuscript submission checklist. These forms can be copied from January or July issues of the Journal or downloaded from our Web site.
Editorial policies
The Journal of the American Academy of Dermatology is a refereed journal designed to meet the continuing education needs of the Academy members and the international dermatologic community.
Statements and opinions expressed in the articles and communications herein are those of the author(s) and not necessarily those of the Editor(s), publisher, or Academy. The Editor(s), publisher, and Academy disclaim any responsibility or liability for such material and do not guarantee, warrant, or endorse any product or service advertised in this publication. Neither do they guarantee any claim made by the manufacturer of such product or service.
Conflict of interest
The Journal requires all authors to acknowledge, on the title page of their manuscript, all funding sources that supported their work as well as all institutional or corporate affiliations of the authors. The title page must also include a publishable statement disclosing any commercial associations, current and over the past 5 years, that might pose a conflict of interest. These include consultant arrangements, stock or other equity ownership, patent licensing arrangements, or payments for conducting or publicizing the study. In addition, authors are required to disclose similar associations with companies that make a competing product. When no competing interests are present, the publishable title page disclosure statement should say so. If the authors have competing or conflicting interests that cannot be disclosed in a publishable statement on the title page, they should explain these as well as the reason for needing confidentiality in the covering letter to the Editor. The Editor asks each reviewer to disclose any competing interests (or to recuse oneself if a competing interest might interfere with one's objectivity). The Editors and members of the editorial staff have registered their competing interests, if any, with the officers of the American Academy of Dermatology. An authorship statement and conflict of interest statement must be submitted with the manuscript. Both forms are included in this issue of the Journal (see last page of Contents for page number).
Special requirements for studies involving live human or animal subjects
Studies involving live human or animal subjects must have been approved by the authors' Institutional Review Board or its equivalent. If applicable, this should be mentioned in the methods section of all manuscripts. Do not identify patients by name or initials; numbers should be used. No other information, including clinical photos or family trees, from which a patient could be identified is permitted unless express written permission from the patient/family is provided at the time of manuscript submission. All clinical investigations must have been conducted according to the Declaration of Helsinki principles.
Randomized trials
Randomized trials must be submitted in a format consistent with the CONSORT statement, along with a completed CONSORT manuscript submission checklist. The word “random?or “randomized?should be in the title. For details and the CONSORT checklist, see Weinstock MA. The JAAD adopts the CONSORT statement. J Am Acad Dermatol 1999;41:1045-7. To obtain a copy of the “CONSORT Checklist for Authors Submitting Reports of Randomized Controlled Trials?you may copy it from the editorial cited immediately above.
Copyright transfer
In accordance with the Copyright Act of 1976, which became effective Jan 1, 1978, the following statement signed by each author must accompany the manuscript submitted: “I, the undersigned author, transfer all copyright ownership of the manuscript referenced above to the American Academy of Dermatology, in the event the work is published. I warrant that the article is original, does not infringe upon any copyright or other proprietary right of any third party, is not under consideration by another journal, and has not been published previously. I have reviewed and approve the submitted version of the manuscript and agree to its publication in the Journal of the American Academy of Dermatology.?A copyright transfer form is included in this issue (see last page of Contents for page number). Author(s) will be consulted, whenever possible, regarding republication of material. Sections/article type guidelines
Continuing medical education: In-depth, substantiated, educational articles presenting core information for the continuing medical education of the practicing dermatologist. Answers to accompanying questions may be submitted to the American Academy of Dermatology office for CME credit. Instructions appear in the front advertising section of the JAAD. See last page of Contents for page numbers.
Reports: Original, in-depth clinical and investigative laboratory research articles. (See “Preparation of Manuscripts.?
Therapy: In-depth critical reviews or reports of a therapeutic modality or treatment procedure.
Clinical review: A current review of a disease or treatment.
Case reports: Brief case reports of unusual interest. Repetition of introductory, text-book type information should be avoided. Most case reports should stick to the case at hand, and should not take the form of a lengthy “Case report and review of the literature.?All patient information in case reports must be adequately de-identified. If identifying information or figures are included, express written permission from the patient(s) must be provided at the time of manuscript submission. In general, case reports should meet the specifications for Brief Reports, although length and number of figures may be negotiated when more than 1000 words or more than 2 figures seem to be required. Cases that can be discussed even more briefly should be sumitted as “Case Notes?(see below). Case reports for which a “review of the literature?seems warranted may be considered for publication in the Case & Review section (see below).
Case & Review: The Case & Review section will present reports of single cases or of a small number of cases along with a review of the literature when such a review seems warranted because the subject has not been sufficiently summarized or reviewed (in textbooks or journals) in the relatively recent past and a new synthesis is required.
Brief reports: Short reports of clinical or scientific observations of unusual interest or of a preliminary or especially timely nature. Maximum text 1000 words not including references and figures, maximum 2 figures or tables. Abstract of up to 50 words.
Dermatologic surgery: Articles emphasizing the surgical aspect of dermatology.
Dermatopathology: Articles emphasizing the pathological descriptions of changes in skin disease.
Commentaries: Brief, substantiated commentary on limited subjects.
Current issues: Brief, provocative, opinionated communications, not necessarily documented, on one limited subject.
Letters: Case notes and Notes & Comments: The correspondence/letters department has two sections. Letters commenting on material previously published in the Journal will be considered for the Notes & Comments section. Concise case reports about one or two patients, early reports of therapeutic trials in one or several patients, and early reports of new drug reactions or reactions to new drugs will be considered for the Case Notes section. Conclusions based on uncontrolled trials and/or limited experience should be stated in appropriately tentative terms. Letters of either type must not exceed 500 words and should ordinarily not cite more than five references. Up to two figures or tables may be included. Comments on articles that have appeared in the Journal and which are intended for publication will be sent to the authors of the article drawing comment for a response, which may be published or sent directly to the commentator at the discretion of the editor. Questions or comments that could be addressed directly to authors (including complaints about missed citations), usually should be, rather than involving the Journal as an intermediary.
Special reports: Items of special interest.
Pearls: Special approaches useful in diagnosis and treatment or surgical management of skin diseases. Maximum 3 double-spaced typewritten pages of text, maximum 3 illustrations.
Book reviews: Books and monographs (domestic and foreign) will be reviewed depending on their interest and value to subscribers. Send books to the Editor, Jeffrey D. Bernhard, MD. No books will be returned.
Supplements
The Journal follows the guidelines for supplements established by the International Committee of Medical Journal Editors. These guidelines are included in the document entitled “Uniform Requirements for Manuscripts Submitted to Biomedical Journals,?which can be found at http://www.icmje.org/. Supplements undergo peer review and are processed in the same fashion as regular submissions to the Journal. All manuscript submission requirements, including clear disclosure of authorship contributions, must be satisfied for each paper. Inquiries about proposed supplements should be directed to the Editor before submitting the supplement. A note on the use of the word “unrestricted?in the description of educational grants: The use of the term “unrestricted?will be limited to situations in which the granting institution has no influence on the selection of the subject, speakers, or authors. In circumstances in which the granting institution has had such influence (as, for example, in organizing a symposium or supplement on a particular subject), it is nonetheless required that the granting organization have no influence over the content of the articles. It is also understood that the authors assume full responsibility for the content of the articles and for complete disclosure of funding sources and potential conflicts of interest.
Electronic publication at www.eblue.org
preBlue Because or urgency, public health importance, or special interest, the Editor may select some reports for internet publication in our preBlue section before they appear in print (“publish-ahead-of-print?.
preBlueprints Some articles and correspondence may be selected for internet publication only in our eBlueprints section (“on-line only publication?. Please note that on-line publication is publication.
The full content of each regular monthly issue is also routinely posted on-line at www.eblue.org.
Preparation of manuscripts
Original manuscripts will be considered for publication.
Correct preparation of the manuscript will expedite the reviewing and publication procedures. Please note the following requirements.
The original page-numbered copy of the manuscript and all supporting material plus two photocopies (not carbon copies) must be submitted to the Editor. The article must be typewritten (one side only), double-spaced, on 22 ?28 cm (8??11 inch) paper with adequate margins.
Once a manuscript is accepted, return two copies of the revised and retyped manuscript and a diskette (high-density only) of the final version of the manuscript. With a felt-tip pen, label diskette with the first author's last name, the manuscript number, and the type of word processing software used. The author accepts responsibility for the submitted diskette exactly matching the printout of the final version of the manuscript. Do not send diskette until instructed to do so.
A completed, signed submission form and checklist for authors must be provided with the manuscript (see last page of Contents for page number).
Style
Manuscripts must conform to acceptable English usage. Consult the latest edition of The Chicago Manual of Style by The University of Chicago Press or the Manual of Style by the AMA for current usage. Abbreviations must be limited primarily to those in general usage.
Generic names must be used. If a trade name is included, it should follow the generic name in parentheses the first time it is mentioned in the abstract or text, but not in the title. Thereafter, generic names only should be used throughout the remainder of the article.
Weights and measurements must be expressed in metric units. Temperatures must be expressed in degrees centigrade.
Title page On the title page, include the title, authors' full names, highest earned academic degrees, and institutional affiliations and locations. The title page must also include a statement of all funding sources for the work as well as a publishable conflict of interest statement (see above for details). Designate one author as correspondent (provide address, telephone and fax numbers, and E-mail address) to receive communications from the Editorial Office and galley proofs from the publisher. The name and address of the author who will receive reprint requests should be noted if different from the correspondent. Please do not designate a resident or fellow as the corresponding author. Start with the title page as page 1.
Abstract Each article must be accompanied by an abstract not exceeding 150 words typed double-spaced on a separate sheet of paper. Abstracts of papers submitted for publication in the Reports, Therapy, Dermatopathology, and Dermatologic Surgery sections may be organized as follows:
| Background: |
What is the major problem that prompted the study? |
| Objective: |
What is the purpose of the study? |
| Methods: |
How was the study done? |
| Results: |
What are the most important findings? |
| Conclusion: |
What is the single most important conclusion? |
Authors who prefer to write nonstructured abstracts may do so if the result communicates the essentials with greater elegance and equal concision. In either event, it is not permissible to state that results or other data will be presented or discussed.
Abbreviations, acronyms Only standard abbreviations are to be used. Consult Scientific Style and Format by the Council of Biology Editors or the AMA's Manual of Style. Abbreviations in the title are not acceptable. They should be avoided in the abstract, if possible. A laboratory or chemical term or a disease process must be spelled out at first mention, with the acronym or abbreviation following in parentheses. List all abbreviations and acronyms on a separate page.
Histologic/microscopic figures The legend must specify stain and magnification. Arrows and arrowheads should be used freely to clarify findings.
References Personal communications should not be cited in the reference list but may appear parenthetically in the text. References must be identified in the text by superscript Arabic numerals in order of their mention. The reference list should be typed double-spaced at the end of the text in numeric sequence. The format should conform to that set forth in “Uniform Requirements for Manuscripts Submitted to Biomedical Journals (Vancouver style)?(Ann Intern Med 1997;126:36-47). Journal titles should conform to the abbreviations in Cumulated Index Medicus.
EXAMPLES OF REFERENCES
List the first six authors followed by et al.:
For journal articles: Kofler H, Wambacher-Gasser B, Topar G, Weinlich G, Schuler G, Hintner H, et al. Intravenous immunoglobulin treatment in therapy-resistant epidermolysis bullosa acquisita. J Am Acad Dermatol 1997;36:331-5.
For books: Hunt TK, editor. Wound healing and wound infection: theory and surgical practice. New York: Appleton-Century-Crofts; 1980.
For chapters in books: McNutt NS, Fishman PM. Metastatic tumors. In: Farmer ER, Hood AP, editors. Pathology of the skin. Norwalk (CT): Appleton & Lange; 1990. p. 465-78.
Illustrations and tables Tables, figures, and legends should supplement, not duplicate, the text. A reasonable number of halftone photographs and line drawings will be published at no extra charge to the author. Color illustrations will be reviewed by the Editor and those considered appropriate will be published free of charge to the authors. Figures must be cited in the text and numbered in order of mention. Figures must be numbered lightly on the back with the first author's last name and an arrow marking the top edge.
Black and white graphs must be legible and clearly printed in jet-black ink on heavy paper; submit 3 sets. Mosby will scan them electronically. The fill for bar graphs or pie charts should be distinctive; avoid shading or dotted patterns. If unavoidable, submit this type of illustration in the form of a glossy photograph for best results. Use thick, solid lines and bold, solid type. Place lettering on a white background; avoid reverse type (white lettering on a dark background). All lettering must be done professionally and should be in proportion to the drawing, graph, or photograph. Typewritten or freehand lettering is unacceptable. Do not send negatives, original artwork, x-ray films, or ECG strips. For black and white photographs, submit 3 sets of glossy prints. Preferred size for submitted illustrations is 5 ?7 inches. Consistency in size within the article is strongly preferred. Any special instructions regarding sizing should be clearly noted.
For color photographs, submit transparencies (slides) and two sets of unmounted prints on glossy paper. If prints have been enhanced and differ from the slides, preference for reproduction should be noted. The quality of the reproduction depends entirely on the quality of the illustrations submitted. Please note that 35 mm transparencies are normally enlarged to twice their original size. If it is important to deviate from this standard, please indicate when file material is submitted. Top for each print (and transparency) must be noted.
Patient consent must accompany recognizable photographs of patients; if not available, indicate clearly in the cover letter. It is important to retain at least one copy of each illustration; only in special circumstances will illustrations be returned.
Figures may be submitted in electronic format. All images should be at least 5 inches wide. Images should be provided in EPS or TIF format on Zip disk, CD, floppy, Jaz, or 3.5 MO. Macintosh or PC is acceptable. Graphics software such as Photoshop and Illustrator, not presentation software such as PowerPoint, CorelDraw, or Harvard Graphics, should be used in the creation of the art. Color images need to be CMYK, at least 300 DPI, and have an accompanying digital proof?B>not a color laser print or color photocopy. Note: This proof will be used at press for color reproduction. Gray scale images should be at least 300 DPI accompanied by a proof. Combinations of gray scale and line art should be at least 1200 DPI accompanied by a proof. Line art (black and white or color) should be at least 1200 DPI and include a proof. Please include hardware and software information on the disk in addition to file names, and first author's name.
Type legends double-spaced on a separate sheet of paper and insert after the references. If an illustration has been published previously, full credit to the original source must be given in the legend.
Tables should be self-explanatory and numbered in Roman numerals according to their mention in the text. Provide a brief title for each. If a table, or any data therein, has been published previously, full credit to the original source must be given in a footnote.
Permissions and patient consent forms Direct quotations, tables, or illustrations that have appeared in copyrighted material must be accompanied by written permission for their use from the copyright owner and the original author along with complete information as to source.
Patient consent forms for publication of recognizable photographs must accompany the manuscript. Patients must be identified by numbers and/or letters, not by name, initials, or hospital record number.
Institutional consent must also be available.
Reprints Single reprints may be obtained from the author. Reprint order forms will be sent to authors after articles are published.
Procedure for review
Some degree of manuscript revision should be expected and regarded as constructive. The author should suggest several reviewers for the manuscript. Every attempt will be made to use at least one suggested reviewer. Authors will be notified on initial receipt of the manuscript. The editorial staff will review the manuscript and will ordinarily send it to at least two reviewers. Reviewers will pay particular attention to scientific accuracy, relevance, novelty, importance, appropriateness of style, and quality of illustrations. Six to 10 weeks is the usual length of time before an author is notified regarding acceptance. Longer delays are possible. A request to submit a revised manuscript does not guarantee that it will be accepted, only that it will be reconsidered, perhaps after additional peer review. Because space in the Journal is limited, the final editorial decision rests not only on the validity of the report, but also on the editors' judgment of a paper's novelty, clarity, importance, and likely degree of interest to the readership. Brevity is appreciated as well. Authors should avoid repeating the same information in the abstract, introduction, and discussion.
Expedited review and publication
Authors who feel that their paper should receive expedited review and/or rapid publication should request it and explain their rationale in the covering letter to the editor. “Publish-ahead-of-print?is available in our preBlue section in the JAAD online at www.eblue.org: online only publication is available in our eBlueprints section. The time frame for rapid review is ordinarily 3 to 4 weeks; for online publication, 6 to 8 weeks from date of acceptance of the final revision. Authors are reminded that as a monthly clinical journal, we do not operate on the time frame of a weeily and do not ordinarily publish “news?items.
Transfer of copyright
I (we), the undersigned author(s), transfer all copyright ownership of the manuscript referenced above to the American Academy of Dermatology, in the event the work is published. I (we) warrant that the article is original, does not infringe upon any copyright or other proprietary right of any third party, is not under consideration by another journal, and has not been published previously. I (we) have reviewed and approve the submitted version of the manuscript and agree to its publication in the Journal of the American Academy of Dermatology.
Each author's name must be typed underneath the signature.
Author(s) signature(s)
____________________________________________
____________________________________________
____________________________________________
____________________________________________
____________________________________________
____________________________________________
Date signed
____________________________________________
____________________________________________
____________________________________________
____________________________________________
____________________________________________
____________________________________________
US Federal Employees: If you are an employee of the US federal government, please sign the following statement: I was an employee of the US federal government when this work was conducted and prepared for publication; therefore the work lies within the public domain and is not subject to the Copyright Act. Ownership of copyright cannot be transferred. If you are not a government employee, do not sign.
Each author's name must be typed underneath the signature.
Author(s) signature(s)
____________________________________________
____________________________________________
____________________________________________
____________________________________________
____________________________________________
____________________________________________
Date signed
____________________________________________
____________________________________________
____________________________________________
____________________________________________
____________________________________________
____________________________________________
Authorship statement
All persons who meet authorship criteria are listed as authors, and all authors certify that they have participated sufficiently in the work to take public responsibility for the content, including participation in the concept, design, analysis, writing, or revision of the manuscript. Furthermore, each author certifies that this material or similar material has not been and will not be submitted to or published in any other publication before its appearance in the Journal of the American Academy of Dermatology. If this study has been or will be presented at a national meeting, indicate the appropriate information on the title page.
Acknowledgment: All persons who have made substantial contributions to the work reported in the manuscript (including writing and editing assistance), but who are not authors, are named in the Acknowledgment and have given me (us) their written permission to be named. If I (we) do not include an acknowledgment, that means I (we) have not received substantial contributions from nonauthors.
Each author's name must be typed underneath the signature.
Author(s) signature(s)
____________________________________________
____________________________________________
____________________________________________
____________________________________________
____________________________________________
____________________________________________
Date signed
____________________________________________
____________________________________________
____________________________________________
____________________________________________
____________________________________________
____________________________________________
Conflict of interest statement
I (we) certify that any affiliations with or involvement (eg, honoraria; education grants; speakers' bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements) in any organization or entity with any financial interest in the subject matter or materials discussed in this manuscript are disclosed in the submission letter and on the title page. If none, state “none?below.
Each author's name must be typed underneath the signature.
Author(s) signature(s)
____________________________________________
____________________________________________
____________________________________________
____________________________________________
____________________________________________
____________________________________________
Date signed
____________________________________________
____________________________________________
____________________________________________
____________________________________________
____________________________________________
____________________________________________
Required submission form and checklist for authors
(Photocopy this page, complete all applicable sections, and submit with manuscript)
Corresponding Author:_________________________________________
Phone No.: _____________________
Fax No.: ______________________
E-mail: _______________________
- Cover letter:
- Title, brief description of manuscript and its significance to dermatologists
- Suggested section
- Explanation of any conflicts of interest
- Possible reviewers
- Signed by corresponding author
- Signed copyright transfer statement (see separate form)
- Signed authorship statement from each author (see separate form)
- Signed conflict of interest statement from each author (see separate form)
- Copy of Institutional Review Board approval for clinical research trials
- CONSORT checklist for randomized trials
- Original and two copies of complete article including title page and abstract
- Manuscript double-spaced with each section beginning on a new page
- Number the pages in the upper right corner, beginning with the title page
- Title page
- Title of article
- Full name(s), academic degrees, and academic, institutional, and relevant corporate affiliations of author(s)
- Name, address, business telephone and fax numbers, and E-mail address of author to whom correspondence should be sent. Do not designate trainees or medical students for this purpose.
- Statement of all funding sources for this work (if none, please state)
- Publishable disclosure statement of potential conflicts of interest for each author. If none, please state: The authors have no conflict of interest to disclose
- Statement on prior presentation
- Reprint request line
- Word count, number of references, tables, and figures
- Abstract (double-spaced), starting on a separate sheet
- References (double-spaced), starting on a separate sheet
- Tables (double-spaced), each on a separate sheet
- Figure legends (double-spaced), starting on a separate sheet
- Abbreviation and acronym list on separate sheet
- Black-and-white illustrations, properly labeled (3 sets of glossy prints)
and/or
- Color illustrations, properly labeled (original transparencies and 2 sets of unmounted prints)
- Patient consent letters (photographic and informed consent)
- Permission to reproduce material published previously
- Contents of the manuscript have not been previously published and are not currently submitted elsewhere
- All human and animal studies are approved by an Institutional Review Board.
- I accept responsibility for the scientific integrity of the work described in this manuscript.
- All listed authors have seen and approved of the manuscript and will sign off on any subsequent manuscript revisions.
____________________________________________
Signature of corresponding author who verifies that above is correct
____________________________________________
Editorial Board
j0910-9622.pdf
|
